World Vaccine Congress 2016

Europe's most successful vaccine event is now entering its 17th year.

For 16 years the World Vaccine Congress in Europe has been the leading event to talk about scientific advances and find new business opportunities within the vaccine sector and this year is no exception.

The 2016 agenda is built to reflect the new activities in the vaccine industry, from a focus on what is going on in the immunotherapy or influenza vaccine fields to parallel tracks on discovery and pre-clinical validation, clinical trials and manufacturing methods. The event is also co-located with the World Veterinary Vaccine Congress and the Immune Profiling World Congress, promising something for everyone who works within the vaccines field.

For 2016 they are building on previous success by making sure that the agenda delves into what is truly innovative in the sector right now and the speakers continue to be true disrupters and trend-setters.

The World Vaccine Congress Europe is a place where collaborations are founded and scientific innovations are sparked.

Price:
Standard final price: EUR 3570
Academic final price: EUR 1785

Speakers:Dr manuel Manuel Carrondo, Director, IBET, Dr Mark Esser, Director of Vaccines and Infectious Disease Translational Medicine, MedImmune, Dr Nicholas Jackson, Vice President, Head of Global Research, Sanofi Pasteur, Dr Pierre A Morgon, CEO, AJ Biologics, Dr Rino Rappuoli, Chief Scientist, GSK Vaccines, Dr Jan Poolman, Head Bacterial Vaccine Discovery and Early Development, Janssen, Ms Jayanthi Wolf, Director and Biologics and Vaccines Safety Assessment Therapeutic Area Leader, Merck